Literature DB >> 3051005

Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle.

G J Cooper1, B Leighton, G D Dimitriadis, M Parry-Billings, J M Kowalchuk, K Howland, J B Rothbard, A C Willis, K B Reid.   

Abstract

Diabetes-associated peptide has recently been isolated and characterized from the amyloid of the islets of Langerhans in type 2 (non-insulin-dependent) diabetics, and immunoreactivity with antibodies to the peptide has been demonstrated in islet B cells of both normal and type 2 diabetic subjects. In view of the evidence presented in this paper that this 37-amino acid peptide may be a hormone present in normal individuals, we now propose the name "amylin" to replace "diabetes-associated peptide." Because increased amylin, deposited as amyloid within the islets of Langerhans, is characteristic of type 2 diabetes, the study below was performed to examine the possible effects of amylin on peripheral glucose metabolism. Whole amylin was synthesized by using solid-phase techniques, with formation of the disulfide linkage by oxidation in dilute aqueous solution and recovery of the peptide by lyophilization. The effects of amylin on glucose metabolism were studied in two preparations in vitro, isolated rat soleus muscle strips and isolated rat adipocytes. In skeletal muscle exposed to 120 nM amylin for 1 hr, there was a marked decrease in both basal and submaximally insulin-stimulated rates of glycogen synthesis, which resulted in significant reduction in the rates of insulin-stimulated glucose uptake. In muscles treated with amylin there was no response at the concentration of insulin required to stimulate glucose uptake half-maximally in untreated (control) muscles. In marked contrast, amylin had no effect on either basal or insulin-stimulated rates of glucose incorporation into either CO2 or triacylglycerol in isolated adipocytes. Therefore, amylin may be a factor in the etiology of the insulin resistance in type 2 diabetes mellitus, as both deposition of the peptide in islet amyloid and decreased rates of glucose uptake and glycogen synthesis in skeletal muscle are characteristic of this condition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3051005      PMCID: PMC282273          DOI: 10.1073/pnas.85.20.7763

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Causes and elimination of erratic blanks in enzymatic metabolite assays involving the use of NAD+ in alkaline hydrazine buffers: improved conditions for the assay of L-glutamate, L-lactate, and other metabolites.

Authors:  P C Engel; J B Jones
Journal:  Anal Biochem       Date:  1978-08-01       Impact factor: 3.365

2.  Diabetes in Macaca nigra: metabolic and histologic changes.

Authors:  C F Howard
Journal:  Diabetologia       Date:  1974-11       Impact factor: 10.122

3.  Light and electron microscopic studies of islet amyloid in diabetic cats.

Authors:  K H Johnson; J B Stevens
Journal:  Diabetes       Date:  1973-02       Impact factor: 9.461

4.  Sensitivity of glucose uptake and lipolysis of white adipocytes of the rat to insulin and effects of some metabolites.

Authors:  A Green; E A Newsholme
Journal:  Biochem J       Date:  1979-05-15       Impact factor: 3.857

5.  Effects of dexamethasone treatment on insulin-stimulated rates of glycolysis and glycogen synthesis in isolated incubated skeletal muscles of the rat.

Authors:  B Leighton; R A Challiss; F J Lozeman; E A Newsholme
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

6.  Contribution of the pentose cycle to glucose metabolism in muscle.

Authors:  M R Green; B R Landau
Journal:  Arch Biochem Biophys       Date:  1965-09       Impact factor: 4.013

7.  Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.

Authors:  R DeFronzo; D Deibert; R Hendler; P Felig; V Soman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Decreased basal, noninsulin-stimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obese-hyperglycemic (ob/ob) mice.

Authors:  G S Cuendet; E G Loten; B Jeanrenaud; A E Renold
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

9.  Modifications of glucose storage and oxidation in nonobese diabetics, measured by continuous indirect calorimetry.

Authors:  H U Meyer; B Curchod; E Maeder; P Pahud; E Jequier; J P Felber
Journal:  Diabetes       Date:  1980-09       Impact factor: 9.461

10.  Insulin resistance in soleus muscle from obese Zucker rats. Involvement of several defective sites.

Authors:  M Crettaz; M Prentki; D Zaninetti; B Jeanrenaud
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

View more
  79 in total

Review 1.  Islet amyloid polypeptide--a novel controversy in diabetes research.

Authors:  P Westermark; K H Johnson; T D O'Brien; C Betsholtz
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

2.  Amyloidogenicity and cytotoxicity of des-Lys-1 human amylin provides insight into amylin self-assembly and highlights the difficulties of defining amyloidogenicity.

Authors:  Kyung-Hoon Lee; Alexander Zhyvoloup; Daniel Raleigh
Journal:  Protein Eng Des Sel       Date:  2019-12-13       Impact factor: 1.650

Review 3.  Central nervous system involvement in diabetes mellitus.

Authors:  Dinesh Selvarajah; Solomon Tesfaye
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

4.  Islet amyloid polypeptide in insulinoma and in the islets of the pancreas of non-diabetic and diabetic subjects.

Authors:  H Toshimori; R Narita; M Nakazato; J Asai; T Mitsukawa; K Kangawa; H Matsuo; K Takahashi; S Matsukura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

5.  Islet amyloid polypeptide (IAPP) is synthesized in the islets of Langerhans. Detection of IAPP polypeptide and IAPP mRNA by combined in situ hybridization and immunohistochemistry in rat pancreas.

Authors:  M Denijn; R A De Weger; A D Van Mansfeld; J A van Unnik; C J Lips
Journal:  Histochemistry       Date:  1992

6.  Islet amyloid polypeptide (IAPP) in the gastrointestinal tract and pancreas of man and rat.

Authors:  H Toshimori; R Narita; M Nakazato; J Asai; T Mitsukawa; K Kangawa; H Matsuo; S Matsukura
Journal:  Cell Tissue Res       Date:  1990-12       Impact factor: 5.249

Review 7.  Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Authors:  Ping Cao; Peter Marek; Harris Noor; Vadim Patsalo; Ling-Hsien Tu; Hui Wang; Andisheh Abedini; Daniel P Raleigh
Journal:  FEBS Lett       Date:  2013-02-01       Impact factor: 4.124

8.  Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.

Authors:  B Ludvik; M Clodi; A Kautzky-Willer; M Schuller; H Graf; E Hartter; G Pacini; R Prager
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes.

Authors:  Judith Miklossy; Hong Qing; Aleksandra Radenovic; Andras Kis; Bertrand Vileno; Forró Làszló; Lisa Miller; Ralph N Martins; Gerard Waeber; Vincent Mooser; Fred Bosman; Kamel Khalili; Nune Darbinian; Patrick L McGeer
Journal:  Neurobiol Aging       Date:  2008-10-23       Impact factor: 4.673

10.  Cyclic N-terminal loop of amylin forms non amyloid fibers.

Authors:  Stephanie M Cope; Sandip Shinde; Robert B Best; Giovanna Ghirlanda; Sara M Vaiana
Journal:  Biophys J       Date:  2013-10-01       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.